TCTR20200525001
Completed
未知
se of Serum Periostin Level to Predict Exacerbation in Moderate to Severe Asthma Patients
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of medicine
- Enrollment
- 24
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients were diagnosed moderate to severe asthma according to Global Strategy for Asthma Management and Prevention (GINA) updated 2018\.
- •Ages over 18 years
Exclusion Criteria
- •Chronic obstructive pulmonary disease (COPD), asthma †COPD overlap, Idiopathic pulmonary fibrosis (IPF),pregnancy women and end\-stage of chronic disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Periostin as a predictor of severe exacerbations in asthmaAsthmaRespiratory - AsthmaACTRN12615000503527Medical Research Institute of New Zealand230
Completed
Not Applicable
A study to determine serum periostin levels over a six month period in adult patients, following a fractureSerum Periostin levels, following a fractureSerum periostin levels, following planned knee or hip joint replacementSerum periostin levels, following open reduction internal fixation (ORIF) surgeryInjuries and Accidents - FracturesMusculoskeletal - Other muscular and skeletal disordersACTRN12614000151639Medical Research Institute of New Zealand102
Completed
Not Applicable
Examining the role of serum periostin as a prognostic marker of asthmaJPRN-UMIN000030674Kyoto University78
Completed
Not Applicable
A study to determine the change in serum periostin level over 12 weeks in adult patients following a severe exacerbation of asthmaACTRN12614000443695Medical Research Institute of New Zealand34
Not yet recruiting
Not Applicable
tility of protein levels in blood to identify complications after pancreatic surgeries in a cancer instituteCTRI/2020/12/029642Tata Memorial Hospital